Home Page Twitter Facebook Linked-In YouTube Home Page Join List-Serve Privacy Policy ADAP Advocacy Association

About ADAPs About Us Contact Us Events Publications Media Clips Press Room Support

About giving more than just a handfull of hope...aaa+

HEAR. HELP. HEAL. HOPE.

The ADAP Advocacy Association (aaa+®) mission is to promote and enhance the AIDS Drug Assistance Programs (ADAPs) and improve access to care for persons living with HIV/AIDS. aaa+® works with advocates, community, health care, government, patients, pharmaceutical companies and other stakeholders to assure that access to services recognize and afford persons living with HIV/AIDS to enjoy a healthy life.

aaa+® is the only national grassroots organization focused exclusively on ADAPs and ensuring that there are adequate resources nationwide to eliminate or prevent waiting lists for services. Our purpose is to better engage people living with HIV/AIDS by providing a platform whereby they can offer their personal experiences, challenges, knowledge, insight and solutions to solving this perpetual problem.

—> Join List-Serve

Breaking News

ADAP Advocacy Association Launches 340B Service Caucus

"New Caucus Brings Patient Perspective to the Debate Over 340B Drug Pricing Program"

WASHINGTON, D.C. - (January 28, 2016) - The ADAP Advocacy Association - also known as aaa+® - today launched its new 340B Service Caucus. The Caucus comes in response to the ongoing debate over the 340B Drug Pricing Program, which requires drug manufacturers to provide outpatient drugs to eligible health care organizations/covered entities at significantly reduced prices.  [PDF | DOC]

ADAP Blog

New 340B Services Caucus Focuses on Patients
By: Brandon M. Macsata, CEO, ADAP Advocacy Association

On January 28, 2016, something peculiar happened in the debate over the future of the 340B Drug Pricing Program. The ADAP Advocacy Association launched its new 340B Service Caucus, thus giving patients living with HIV/AIDS a seat at the table.

The Health Resources and Services Administration (HRSA) summarizes the program as follows:

"The 340B Drug Pricing Program requires drug manufacturers to provide outpatient drugs to eligible health care organizations/covered entities at significantly reduced prices. The 340B Program enables covered entities to stretch scarce Federal resources as far as possible, reaching more eligible patients and providing more comprehensive services. Eligible health care organizations/covered entities are defined in statute and include HRSA-supported health centers and look-alikes, Ryan White clinics and State AIDS Drug Assistance programs, Medicare/Medicaid Disproportionate Share Hospitals, children’s hospitals, and other safety net providers.”

CLICK HERE to read more.

ADAP Update

ADAPs with Waiting Lists
(35 individuals in 1 state(s) on the ADAP Waiting List as of July 28, 2014)
Source: The ADAP Watch, National Alliance of State & Territorial AIDS Directors (NASTAD).

  • Eleven ADAPs have had cost-containment measures in place since April 1, 2013 (reported as of July 15, 2014).
  • No ADAPs currently anticipate additional cost-containment measures prior to March 31, 2015.

» Go to the ADAP Watch

Support Our Scholarship Fund

ADAP Directory

Home · Join List-Serve · About ADAPs · About Us · Blog · Events · Publications
Media Clips · Press Room · Support · Privacy · Contact Us